Protagenic Therapeutics, Inc.\new

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

PTIX

organization

SIC: 2834

SEC Insider

$17.14B

198 transactions

Summary

Protagenic Therapeutics, Inc.\new (PTIX) is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $17.13BSales: $410K39 insiders

Date	Insider	Type	Value
2024-03-25	ARMEN GARO H(Executive Chairman)	A	$435K
2024-03-25	Arrow Alexander K.(Chief Financial Officer)	A	$174K
2024-03-25	Buell Jennifer	A	$131K
2024-03-25	Stein Robert Benjamin	A	$131K
2024-03-25	Corvese Brian	A	$76K
2024-03-25	Barrage Khalil	A	$39K
2024-03-25	WRIGHT TIMOTHY R	A	$37K
2022-05-17	Arrow Alexander K.(Chief Financial Officer)	Buy	$16K
2023-10-12	Arrow Alexander K.(Chief Financial Officer)	Buy	$6K
2021-06-03	Arrow Alexander K.(Chief Financial Officer)	Buy	$6K
2022-05-18	Arrow Alexander K.(Chief Financial Officer)	Buy	$6K
2021-05-18	Arrow Alexander K.(Chief Financial Officer)	Buy	$6K
2021-05-18	Arrow Alexander K.(Chief Financial Officer)	Buy	$4K
2021-05-27	Arrow Alexander K.(Chief Financial Officer)	Buy	$1K
2021-06-02	Arrow Alexander K.(Chief Financial Officer)	Buy	$38
2021-05-26	Barrage Khalil	A	$0
2021-05-03	Barrage Khalil	M	$0
2021-05-03	Barrage Khalil	M	$0
2021-05-03	Barrage Khalil	M	$0
2021-05-03	Barrage Khalil	M	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Protagenic Therapeutics, Inc.\new — Contributions, Lobbying & Contracts | Poliscope